Literature DB >> 33546431

The Role of ND10 Nuclear Bodies in Herpesvirus Infection: A Frenemy for the Virus?

Behdokht Jan Fada1, Eleazar Reward1, Haidong Gu1.   

Abstract

Nuclear domains 10 (ND10), a.k.a. promyelocytic leukemia nuclear bodies (PML-NBs), are membraneless subnuclear domains that are highly dynamic in their protein composition in response to cellular cues. They are known to be involved in many key cellular processes including DNA damage response, transcription regulation, apoptosis, oncogenesis, and antiviral defenses. The diversity and dynamics of ND10 residents enable them to play seemingly opposite roles under different physiological conditions. Although the molecular mechanisms are not completely clear, the pro- and anti-cancer effects of ND10 have been well established in tumorigenesis. However, in herpesvirus research, until the recently emerged evidence of pro-viral contributions, ND10 nuclear bodies have been generally recognized as part of the intrinsic antiviral defenses that converge to the incoming viral DNA to inhibit the viral gene expression. In this review, we evaluate the newly discovered pro-infection influences of ND10 in various human herpesviruses and analyze their molecular foundation along with the traditional antiviral functions of ND10. We hope to shed light on the explicit role of ND10 in both the lytic and latent cycles of herpesvirus infection, which is imperative to the delineation of herpes pathogenesis and the development of prophylactic/therapeutic treatments for herpetic diseases.

Entities:  

Keywords:  ND10; PML nuclear bodies; antiviral defense; herpesvirus; virus-host interaction

Mesh:

Substances:

Year:  2021        PMID: 33546431      PMCID: PMC7913651          DOI: 10.3390/v13020239

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  178 in total

1.  Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.

Authors:  M K Chelbi-Alix; H de Thé
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

2.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Human cytomegalovirus immediate-early gene expression is restricted by the nuclear domain 10 component Sp100.

Authors:  Martina Adler; Nina Tavalai; Regina Müller; Thomas Stamminger
Journal:  J Gen Virol       Date:  2011-04-06       Impact factor: 3.891

4.  The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments.

Authors:  Pei Xu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

5.  Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17.

Authors:  J Borrow; A D Goddard; D Sheer; E Solomon
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

6.  Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter.

Authors:  David L Woodhall; Ian J Groves; Matthew B Reeves; Gavin Wilkinson; John H Sinclair
Journal:  J Biol Chem       Date:  2006-10-11       Impact factor: 5.157

7.  Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection.

Authors:  Vera Lukashchuk; Steven McFarlane; Roger D Everett; Chris M Preston
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

Review 8.  PML and PML nuclear bodies: implications in antiviral defence.

Authors:  Roger D Everett; Mounira K Chelbi-Alix
Journal:  Biochimie       Date:  2007-01-27       Impact factor: 4.079

9.  Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.

Authors:  T Carvalho; J S Seeler; K Ohman; P Jordan; U Pettersson; G Akusjärvi; M Carmo-Fonseca; A Dejean
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

Review 10.  The function, regulation and therapeutic implications of the tumor suppressor protein, PML.

Authors:  Dongyin Guan; Hung-Ying Kao
Journal:  Cell Biosci       Date:  2015-11-04       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.